Does ERIBULIN Cause Breast cancer? 106 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 106 reports of Breast cancer have been filed in association with ERIBULIN (eribulin mesylate). This represents 2.1% of all adverse event reports for ERIBULIN.
106
Reports of Breast cancer with ERIBULIN
2.1%
of all ERIBULIN reports
20
Deaths
38
Hospitalizations
How Dangerous Is Breast cancer From ERIBULIN?
Of the 106 reports, 20 (18.9%) resulted in death, 38 (35.8%) required hospitalization, and 2 (1.9%) were considered life-threatening.
Is Breast cancer Listed in the Official Label?
Yes, Breast cancer is listed as a known adverse reaction in the official FDA drug label for ERIBULIN.
What Other Side Effects Does ERIBULIN Cause?
Neutropenia (675)
Malignant neoplasm progression (594)
Myelosuppression (520)
Febrile neutropenia (448)
Neutrophil count decreased (294)
Neuropathy peripheral (290)
White blood cell count decreased (289)
Pyrexia (275)
Disease progression (211)
Fatigue (209)
What Other Drugs Cause Breast cancer?
RANITIDINE (45,666)
LETROZOLE (1,393)
ETANERCEPT (1,303)
METHOTREXATE (936)
ADALIMUMAB (894)
INFLIXIMAB (789)
RIBOCICLIB (788)
FULVESTRANT (684)
DENOSUMAB (671)
ABATACEPT (617)
Which ERIBULIN Alternatives Have Lower Breast cancer Risk?
ERIBULIN vs ERLOTINIB
ERIBULIN vs ERTAPENEM
ERIBULIN vs ERTUGLIFLOZIN PIDOLATE
ERIBULIN vs ERYTHROMYCIN
ERIBULIN vs ERYTHROMYCIN ETHYLSUCCINATE